News


All News

Washington - The Food and Drug Administration is warning patients on the psoriasis drug Raptiva (Genentech) about the risk of developing progressive multifocal leukoencephatolopathy (PML), the Wall Street Journal reports.

Stiefel Laboratories is partnering with Ventiv Professional Development Group (PDG) to extend its global selling skills platform into new markets, Globe Newswire reports.

San Francisco is an eclectic mix of districts, home to more than 40 neighborhoods. Here is a sampling of some of the neighborhoods you might run across during your stay in the city by the Bay. Then, turn to the San Francisco Attractions article for some activities in many of the various neighborhoods.

If your practice hasn't jumped on the eco-friendly bus already, maybe it's time to catch a ride. 'Going green' can make good business sense. Savvy dermatology practices recognize that consumers gravitate to businesses they perceive as socially conscious. In addition to attracting patients and helping the environment, being environmentally friendly may also help you reduce costs.

With increasing frequency, I have noticed that many audience members at medical meetings are dividing their attention between the speakers and their Blackberries and laptops. Some audience members keep both their Blackberries and laptops running throughout the meeting, and are not engaged at all in the meeting - but I am sure they will claim CME credit for "being there."

As a busy professional or business owner, you're affected by our troubled economy on two fronts. First is your obvious concern about revenues and maintaining a healthy bottom line. Then, like everyone else, you also have the worry about your personal finances.

Post-transplant lymphoproliferative disorder is lymphocyte proliferation in patients following post-transplant immunosuppression and is the most common neoplasm in pediatric organ transplant recipients. Due to the increased frequency of organ transplantation, dermatologists should be aware of the cutaneous presentation, as a timely diagnosis and treatment is crucial for a favorable prognosis.

Organ transplant recipients (OTRs) have an increased risk of carcinogenesis most likely due to the immunosuppressive medication they need to take. Sebaceous carcinoma is a rare occurrence, however, as witnessed in two recent case studies, this highly aggressive malignant tumor can occur in immunosuppressed OTRs, making the thorough screening programs a high priority in these patients.